Indo-Bangla Pharmaceuticals (DHA:IBP) Total Liabilities: BDT0.00 Mil (As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT17.60
View Full Analysis

What is Indo-Bangla Pharmaceuticals Total Liabilities?

Indo-Bangla Pharmaceuticals DHA:IBP +6.02% 32 Total Liabilities is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's Total Liabilities for the quarter that ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Total Liabilities Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Total Liabilities

Indo-Bangla Pharmaceuticals Semi-Annual Data
Total Liabilities
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Indo-Bangla Pharmaceuticals's Total Liabilities for the fiscal year that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (A: . 20 )-Total Equity (A: . 20 )
=N/A-N/A
=N/A

Indo-Bangla Pharmaceuticals's Total Liabilities for the quarter that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (Q: . 20 )-Total Equity (Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of BDT0.00 Mil mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Total Liabilities of BDT0.00 Mil as of . 20. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Total Liabilities too high?
Indo-Bangla Pharmaceuticals' current Total Liabilities is BDT0.00 Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Total Liabilities compare to ?
Indo-Bangla Pharmaceuticals' Total Liabilities of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Total Liabilities is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Total Liabilities of BDT0.00 Mil. The current Total Liabilities is BDT0.00 Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Total Liabilities is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT17.60
Price